FTC challenges Akorn-Hi-Tech Pharmacal deal
MLex Summary: The US Federal Trade Commission issued a complaint against pharmaceutical company Akorn''s acquisition of rival Hi-Tech Pharmacal, alleging their transaction would reduce competition in the markets for three generic prescription eye...To view the full article, register now.
Already a subscriber? Click here to view full article